Condition: Proliferative Diabetic Retinopathy (PDR) · Sponsor: Jaeb Center for Health Research
This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combination a of faricimab + PRP or vitrectomy + endolaser. The participants will be followed for 3 years. The study will evaluate long-term visual acuity as well as differences in number of injections, procedures, and complications during follow-up (after completion of randomization treatment), and cost.
This description comes directly from the study's public registry record.
Cynthia Stockdale · 8139758690 · drcrnet@jaeb.org
Always discuss trial participation with your own doctor first.
| Retina Associates of Southern California | Huntington Beach, California, United States | Recruiting |
| Loma Linda University | Loma Linda, California, United States | Recruiting |
| California Retina Consultants | Santa Barbara, California, United States | Recruiting |
| University of Florida - Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Florida Retina Consultants | Lakeland, Florida, United States | Recruiting |
| Ophthalmic Partners of Florida, PA dba Central Florida Retina | Orlando, Florida, United States | Recruiting |
| Retina Associates of Florida, LLC | Tampa, Florida, United States | Recruiting |
| Emory Eye Center | Atlanta, Georgia, United States | Recruiting |
| Southeast Retina Center, P.C. | Augusta, Georgia, United States | Recruiting |
| Illinois Retina Associates SC Oak Park Site | Oak Park, Illinois, United States | Recruiting |
| Midwest Eye Institute | Carmel, Indiana, United States | Recruiting |
| The Trustees of Indiana University | Indianapolis, Indiana, United States | Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06790784